Structure Therapeutics Reports Breakthrough Weight-Loss Results for Oral GLP-1 Candidate Aleniglipron
Phase 2b and ACCESS II studies show up to 15.3% weight reduction with promising tolerability, positioning aleniglipron as a potential ...
Phase 2b and ACCESS II studies show up to 15.3% weight reduction with promising tolerability, positioning aleniglipron as a potential ...
Broadcom–Microsoft chip talks, IBM’s $11B Confluent deal, and a hostile bid for Warner Bros. Discovery add momentum to a market ...
CEO Luke Lloyd and CIO Colin Symons highlight targeted buying opportunities in AVAV, CRWV, and select crypto names while preparing ...
A transformational merger reshapes Hollywood as the world’s largest streaming platform gains control of one of entertainment’s most iconic studios ...
Lisa Su signals compliance with the new trade framework as Washington reshapes AI-chip exports—and legal questions mount over whether the ...
Growing investor confidence signals that Google’s custom AI semiconductors may become a major new revenue engine — and a powerful ...
Pat Gelsinger says tech giants are funding their own demand — and warns that energy, not capital, is the real ...
Rising credit default swap costs highlight investor fears that the AI infrastructure frenzy is inflating a new bubble in corporate ...
After years of financial turbulence, the planemaker outlines a path back to positive cash generation—and ultimately $10 billion annually Boeing ...
With earnings rising faster than expected and standout performances from tech leaders like MongoDB, investors head into December with renewed ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?